# Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance
Canonical URL: https://biopharmsignal.com/news/AXDX/accelerate-diagnostics-submits-wave-system-and-gram-negative-positive-blood-culture-menu-to-the-fda-for-510-k-clearance
Ticker: AXDX
Company: Accelerate Diagnostics
Source: Accelerate Diagnostics
Published: 2025-03-21 17:52 EST
Original Source URL: https://ir.axdx.com
## Article Body
No article body is available yet.
## Recent Company News
- 2025-05-08 13:00 EST — [Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets](https://biopharmsignal.com/news/AXDX/accelerate-diagnostics-files-for-chapter-11-protection-and-agrees-to-terms-to-sell-substantially-all-assets) — Source: Accelerate Diagnostics
- 2025-03-21 17:52 EST — [Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance](https://biopharmsignal.com/news/AXDX/accelerate-diagnostics-submits-wave-system-and-gram-negative-positive-blood-culture-menu-to-the-fda-for-510-k-clearance) — Source: Accelerate Diagnostics
- 2025-03-21 12:30 EST — [Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results](https://biopharmsignal.com/news/AXDX/accelerate-diagnostics-reports-fourth-quarter-and-full-year-2024-financial-results) — Source: Accelerate Diagnostics
- 2025-01-10 21:05 EST — [Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results](https://biopharmsignal.com/news/AXDX/accelerate-diagnostics-announces-certain-preliminary-fourth-quarter-and-full-year-2024-results) — Source: Accelerate Diagnostics
- 2024-11-07 21:05 EST — [Accelerate Diagnostics Reports Third Quarter 2024 Financial Results](https://biopharmsignal.com/news/AXDX/accelerate-diagnostics-reports-third-quarter-2024-financial-results) — Source: Accelerate Diagnostics
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)